Supplementary Table 2.
Identification of Immunoglobulins and Complement in Patients Infected With SARS-CoV-2
| Characteristic | Patients (n = 30) | Diarrhea group (n = 15) | Non-diarrhea group (n = 15) | P value |
|---|---|---|---|---|
| IgE (IU/mL; normal range 1–190) | 92.02 ± 110.29 | 79.36 ± 120.60 | 99.25 ± 108.02 | .638 |
| Increased, n (%) | 6 (20) | 2 (13) | 4 (27) | .651 |
| IgG (g/L; normal range 7.51–15.60) | 11.85 ± 2.04 | 11.45 ± 1.87 | 12.09 ± 2.17 | .394 |
| IgA (g/L; normal range 0.82–4.53) | 1.95 ± 0.75 | 2.14 ± 0.93 | 1.83 ± 0.63 | .294 |
| IgM (g/L; normal range 0.460–3.040) | 1.34 ± 0.74 | 1.29 ± 0.34 | 1.43 ± 0.90 | .578 |
| C3 (g/L; normal range 0.790–1.520) | 0.81 ± 0.19 | 0.79 ± 0.20 | 0.82 ± 0.19 | .677 |
| Decreased, n (%) | 14 (47) | 6 (40) | 8 (53) | .715 |
| C4 (g/L; normal range 0.160–0.380) | 0.27 ± 0.07 | 0.25 ± 0.08 | 0.28 ± 0.07 | .284 |
C, complement; IG, immunoglobulin; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.